Nanoparticle–allergen complexes for allergen immunotherapy

Abstract

Allergen-specific immunotherapy was introduced in clinical settings more than 100 years ago. It remains the only curative approach to treating allergic disorders that ameliorates symptoms, reduces medication costs, and blocks the onset of new sensitizations. Despite this clinical evidence and knowledge of some immunological mechanisms, there remain some open questions regarding the safety and efficacy of this treatment. This suggests the need for novel therapeutic approaches that attempt to reduce the dose and frequency of treatment administration, improving patient compliance, and reducing costs. In this context, the use of novel adjuvants has been proposed and, in recent years, biomedical applications using nanoparticles have been exploited in the attempt to find formulations with improved stability, bioavailability, favorable biodistribution profiles, and the capability of targeting specific cell populations. In this article, we review some of the most relevant regulatory aspects and challenges concerning nanoparticle-based formulations with immunomodulatory potential, their related immunosafety issues, and the nature of the nanoparticles most widely employed in the allergy field. Furthermore, we report in vitro and in vivo data published using allergen/nanoparticle systems, discuss their impact on the immune system in terms of immunomodulatory activity and the reduction of side effects, and show that this strategy is a novel and promising tool for the development of allergy vaccines.

Der p 2.1 Peptide Abrogates House Dust Mites-Induced Asthma Features in Mice and Humanized Mice by Inhibiting DC-Mediated T Cell Polarization

“…Indeed, Martıńez and colleagues showed that the combination of several Der p allergen-derived peptides exhibits anti-inflammatory properties (52). Moreover, the use of nanoparticles as adjuvants (53) in allergen-derived peptide immunotherapy could potentially improve their ability to polarize innate and adaptive cells into a tolerogenic phenotype.…”

Chitin-Based Double-Network Hydrogel as Potential Superficial Soft-Tissue-Repairing Materials

“…4,5 Because of the excellent hydrophilicity, biocompatibility and biodegradability, the hydrogels constructed by cellulose 6 , alginate 7 , collagen 8 , dextran 9 , silk 10 and hyaluronan 11 are regularly considered as candidates for artificial tissue, scaffolds and extracellular matrix. But the poor bacterial barrier capacity restricts the direct applications except for embedding with antibiotics, metal ions or nanoparticles [12][13][14][15] , which also brings in possible inflammation and allergy in vivo 16,17 . Natural polymer extracted from marine crustaceans and fungi, so-called chitin and its derivatives, chitosan, which has also been proved to accelerate fibroblast proliferation, are regarded as more promising matrix as wound repairing materials 18,19 .…”

Analysis of the Exposure of Organisms to the Action of Nanomaterials

“…Nanopharmacology is the fastest growing field of nanomedicine [5]. Over the past two decades, nanopharmaceuticals have been used to treat cancer, diabetes, asthmatic diseases, allergies and various types of infection [6][7][8][9][10]. Nanoparticles are also an effective tool for delivering biopharmaceuticals.…”